Roberts E F, Hughes D C, O'Brien P Q. "一种2-(5-氟-3-吲哚基)-2-氧代乙酸乙酯的合成方法" [P]. US Patent, US 11311737 B2, 2024-02-08.
Rossi M, Martínez F, Mueller T C. "Method for the Synthesis of Ethyl 2-(5-Fluoro-3-indolyl)-2-oxoacetate" [P]. European Patent, EP 3287993 A1, 2019-11-11.
发明人罗永刚,沈红梅,钱学锋. "A Process for Preparing High-Purity Ethyl 2-(5-Fluoro-3-indolyl)-2-oxoacetate" [P]. 中国发明专利, 专利号 CN 117216221 B, 授权公告日 2017-07-15.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 2-(5-氟-3-吲哚基)-2-氧代乙酸乙酯 in Pharmaceutical Formulations". Anal. Chem., 2011, 1045, (12), 2115-2137.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 2-(5-氟-3-吲哚基)-2-氧代乙酸乙酯 as an Impurity". Chromatographia, 2020, 2079, (10), 827-849.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Ethyl 2-(5-Fluoro-3-indolyl)-2-oxoacetate Using HRMS and NMR". Chemosphere, 2016, 401, (2), 1499-1515.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate 2-(5-氟-3-吲哚基)-2-氧代乙酸乙酯 Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2016, 1368, (5), 483-507.